Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

NCT05508906

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • University of California San Francisco Health San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Advent Health Hematology and Oncology Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

NCT06784193

Conditions
Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC), +17 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University Medical Center - New Orleans New Orleans, Louisiana, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START - Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

The COMPASSION Study

NCT06507930

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +7 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

NCT05216432

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California-San Diego San Diego, California, United States
  • HealthONE Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View all 37 locations
View Trial Details
Recruiting

HER-2 B Cell Peptide Vaccine

NCT06414733

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
Locations
  • Indiana University Melvin & Bren Simon Comprehensive Cancer Center Indianpolis, Indiana, United States
View Trial Details
Recruiting

Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer

NCT07008976

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Bengbu, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
View all 31 locations
View Trial Details

Related conditions